Cardiac Prosthetic Devices Market Size & Share - Industry Trend and Forecast 2013 - 2019

Transparency Market Research in its recently published report on the global cardiac prosthetic devices market states that the market is extremely fragmented because of the presence of a copious number of players – both existing well-entrenched ones and upcoming ones. To stay ahead of competition in such a market, players are seen banking upon product development by leveraging the latest technologies.

Some of the companies that have come of hold substantial share in the market for cardiac prosthetic devices by banking upon the aforementioned and other strategies are Boston Scientific Corporation, Edwards Lifesciences Corporation, Sorin Group, Medtronic, Inc., and St. Jude Medical.

Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1721

The report finds that rising at a healthy clip, the market’s estimated valuation would be US$5,290.0 million by 2019.

Cardiac prosthetic devices can be broadly classified into heart valves and pacemakers. While the pacemakers can be further segmented into heart valves and pacemakers, the heart valves can be further segmented into tissue heart valves, transcatheter heart valves, and mechanical heart valves. From a geographical standpoint, North America at present holds a leading share because of the superior technology, updated infrastructure, and presence of well-trained healthcare professional. Another factor stoking the market in the region is the rising instances of cardiovascular disease and sound healthcare and reimbursement policies.

Rising Pool of Elderly Highly Prone to Cardiac Conditions Drives Market

Cardiac prosthetics devices supplant diseased or damaged part of a body – they mainly find usage in tackling of blockages in heart valves. “Cardiac prosthetic devices implants are being widely adopted owing to the growth in the patients’ pool having valvular conditions. Prosthetic valve endocarditis (PVE), mechanical hemolytic anemia, prosthetic valve thrombosis (PVT), and thromboembolism are to name a few complications resulting from the failure of primary valves,” explains the lead analyst of our report.

The cardiac prosthetics devices serve to reduce mortality and morbidity rates by replacing the diseased valves. A heart valve disease, without timely treatment, can cause a variety heart ailments, namely heart failure, stroke, blood clots, and cardiac arrest. And with a rising number of geriatric population who are highly susceptible to cardiac issues and also because of the lifestyle changes leading to such health problems even in the younger lot, the devices are seeing swift uptake. Adds the lead analyst of our report, “Over 60, 000 patients are undergoing heart valve replacement in the U.S. annually. This has majorly fuelled demand for cardiac prosthetic devices.”

Enquiry for Discount on this Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1721

Focus on Product Development Bodes Well for Market

In addition to the surging cases of blockages in heart valves, the market for cardiac prosthetics devices is also being boosted by the continued thrust on product development. Major players are seen pouring money into research and development of better devices built from superior materials and underpinned by more sophisticated technologies.

On the flipside, the market is being negatively affected by the expensiveness of the products and the associated procedures.

This review is based on the findings of a TMR report, titled, “Cardiac Prosthetic Devices Market (Type – Heart Valves (Mechanical Heart Valves, Tissue Heart Valves (Stented Tissue Valve and Stentless Tissue Valve), and Transcatheter Heart Valves) and Pacemaker (Implantable Pacemaker and External Pacemaker) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013–2019.”

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

This release was published on openPR.